دورية أكاديمية

PCN38 Health-Related Quality of Life (QOL) in Monarch PLUS: A Phase 3 Trial of Abemaciclib PLUS Nonsteroidal Aromatase Inhibitor (NSAI) or Fulvestrant for Women with HR+/HER2- Advanced Breast Cancer (ABC)

التفاصيل البيبلوغرافية
العنوان: PCN38 Health-Related Quality of Life (QOL) in Monarch PLUS: A Phase 3 Trial of Abemaciclib PLUS Nonsteroidal Aromatase Inhibitor (NSAI) or Fulvestrant for Women with HR+/HER2- Advanced Breast Cancer (ABC)
المؤلفون: Hu, X.C., Zhang, Q.Y., Sun, T., Yin, Y.M., Li, H.P., Yan, M., Tong, Z.S., Oppermann, C.P., Liu, Y.P., Han, R.B., Wang, N., Zhang, Y.L., Zhang, W.L., Jiang, Z.F.
المصدر: Value in Health ; volume 23, page S427 ; ISSN 1098-3015
بيانات النشر: Elsevier BV
سنة النشر: 2020
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Public Health, Environmental and Occupational Health, Health Policy
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.jval.2020.08.175
الإتاحة: https://doi.org/10.1016/j.jval.2020.08.175Test
https://api.elsevier.com/content/article/PII:S1098301520324311?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1098301520324311?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/
رقم الانضمام: edsbas.B66EB7C1
قاعدة البيانات: BASE